WHO ICTRP trial
C1-inhibitor improves efficacy of red blood cell transfusion in patients…
EUCTR2012-003710-13-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-003710-13-NL |
|---|---|
| Public title | C1-inhibitor improves efficacy of red blood cell transfusion in patients suffering from autoimmune hemolytic anemia – an open-labeled pilot trial |
| Scientific title | C1-inhibitor improves efficacy of red blood cell transfusion in patients suffering from autoimmune hemolytic anemia – an open-labeled pilot trial - C1-inhibitor improves efficacy of red blood cell transfusion in patients suffering from autoimmune h |
| Primary sponsor | Academic Medical Center |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Netherlands |
| Conditions | AutoImmune Hemolytic Anemia MedDRA version: 20.0 Level: LLT Classification code 10003825 Term: Autoimmune hemolytic anemia System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15] |
| Interventions | Trade Name: CINRYZE® (C1 esterase inhibitor [human]) Pharmaceutical Form: Concentrate and solvent for solution for infusion |
| Registration date | Mar 21, 2013 |
| Target size | 10 |
| Secondary IDs | NL41820.018.12 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: